We cut our target price (TP) by 12% as we believe VNM’s low-single-digit 2021-2026 EPS CAGR of 4% (vs 2015-2020 EPS CAGR of 7%) that is underpinned by constricted growth prospects will restrain the stock from a strong valuation re-rating.